25021-263Level 3
Doxorubicin Hydrochloride Liposome (Doxorubicin Hydrochloride)
**Product type:** Human Prescription Drug
**Active ingredient:** DOXORUBICIN HYDROCHLORIDE
**Strength:** 2 mg/mL
**Dosage form:** Injection, Suspension, Liposomal
**Route:** Intravenous
**Labeler:** Sagent Pharmaceuticals
**Marketing category:** ANDA (ANDA219881)
**Pharmacologic class:** Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/25021-263Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.